A clinical trial assessing a novel BenevolentAI candidate for treatment of ulcerative colitis
Latest Information Update: 20 Oct 2021
At a glance
- Drugs Ulcerative colitis therapeutic-BenevolentAI (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors BenevolentAI
- 20 Oct 2021 New trial record
- 14 Oct 2021 According to BenevolentAI media release, this trial is planned to initiate in early 2023.